SurModics, Inc. (SRDX) Tops Q2 EPS by 2c; Approves $50M Buyback; Reafforms Outlook
Tweet
Share
E-mailGet Alerts SRDX Hot Sheet
Price: $42.98 --0%
Financial Fact:
Other income (loss): 17K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Other income (loss): 17K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
SurModics, Inc. (NASDAQ: SRDX) reported Q2 EPS of $0.14, $0.02 better than the analyst estimate of $0.12. Revenue for the quarter came in at $12.2 million versus the consensus estimate of $12.3 million.
SurModics, Inc. reaffirmed FY2012 guidance.
Approves $50 million buyback.
For earnings history and earnings-related data on SurModics, Inc. (SRDX) click here.
SurModics, Inc. reaffirmed FY2012 guidance.
Approves $50 million buyback.
For earnings history and earnings-related data on SurModics, Inc. (SRDX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Is the global equity rally broadening? UBS weighs in
- CoStar Group acquires Zonda for $800M, adding new home data
Create E-mail Alert Related Categories
Earnings, Guidance, Stock BuybacksRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
